CMV colitis: Difference between revisions

No edit summary
 
(9 intermediate revisions by 4 users not shown)
Line 1: Line 1:
==Background==
==Background==
*CMV is part of the Herpesviridae family
*50-80% of the world's population is seropositive for CMV
*Causes a mild or undetectable infection in immunocompetent hosts
*Severe systemic illness is found in immunosuppressed hosts


==Clinical Presentation==
==Clinical Features==
*[[Fever]]
*Anorexia
*Malaise
*[[Abdominal pain]], Abdominal distention, [[constipation]]
*[[Nausea/vomiting]]
*Chronic watery [[diarrhea]]
*[[rectal bleeding|Bloody diarrhea]]
*Worsening symptoms of [[inflammatory bowel disease]]
*Weight loss
*[[Dehydration]]


==Differential Diagnosis==
==Differential Diagnosis==
{{Colitis DDX}}


==Diagnosis==
{{CMV types}}
 
==Evaluation==


==Management==
==Management==
{{CMV colitis treatment}}


==Disposition==
==Disposition==
{{CMV colitis treatment}}
==See Also==
==See Also==
*[[Cytomegalovirus (CMV) infection]]
*[[Cytomegalovirus (CMV) infection]]

Latest revision as of 20:03, 29 September 2019

Background

  • CMV is part of the Herpesviridae family
  • 50-80% of the world's population is seropositive for CMV
  • Causes a mild or undetectable infection in immunocompetent hosts
  • Severe systemic illness is found in immunosuppressed hosts

Clinical Features

Differential Diagnosis

Colitis

CMV Diseases

Evaluation

Management

  • Ganciclovir 5mg/kg IV q12hrs x 21 days (or until resolution of symptoms)
  • Foscarnet 90mg/kg IV q12hrs daily x 21 days (or until resolution of symptoms)

Disposition

See Also

External Links

References